Prevalence of Vertebral Fractures in Patients With Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

192

Participants

Timeline

Start Date

July 29, 2019

Primary Completion Date

March 2, 2021

Study Completion Date

March 2, 2021

Conditions
Diabetes Mellitus, Type 1Bone FractureBone Health
Interventions
DIAGNOSTIC_TEST

Clinical tests

The investigators perform the following clinical tests: vibration threshold test, monofilament test, and height, weight and waist circumference measurement in every participant.

DIAGNOSTIC_TEST

Clinical tests

The investigators perform the following clinical tests: height, weight and waist circumference measurement in every participant.

DIAGNOSTIC_TEST

Biochemical tests

The investigators perform blood and urine tests in every participant.

DIAGNOSTIC_TEST

DXA scan

The investigators perform a dual energy x-ray absorptiometry (DXA scan or osteodensitometry) in every participant.

DIAGNOSTIC_TEST

AGE Reader

The investigators perform a skin advanced glycation end products (AGEs) measurement with the AGE Reader machine in every participant.

Trial Locations (2)

H2W 1R7

Institut de recherches cliniques de Montréal (IRCM), Montreal

G1V 4G2

Centre de recherche du CHU de Québec - Université Laval, Québec

All Listed Sponsors
lead

CHU de Quebec-Universite Laval

OTHER

NCT04064437 - Prevalence of Vertebral Fractures in Patients With Type 1 Diabetes | Biotech Hunter | Biotech Hunter